Loading…
Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (From the RIBS IV and V Randomized Trials)
Abstract Treatment of patients with drug-eluting stent (DES) in-stent restenosis (ISR) is particularly challenging. We sought to compare results of drug-eluting balloons (DEB) in patients with DES-ISR with those in patients with bare-metal stent (BMS) ISR. A pooled analysis of the RIBS IV and RIBS V...
Saved in:
Published in: | The American journal of cardiology 2017-04, Vol.119 (7), p.983-990 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract Treatment of patients with drug-eluting stent (DES) in-stent restenosis (ISR) is particularly challenging. We sought to compare results of drug-eluting balloons (DEB) in patients with DES-ISR with those in patients with bare-metal stent (BMS) ISR. A pooled analysis of the RIBS IV and RIBS V randomized trials was performed. Both trials had identical inclusion/exclusion criteria. Results of DEB in 95 patients with BMS-ISR and 154 patients with DES-ISR were compared. Patients with DES-ISR were more frequently diabetics, presented more often as an acute coronary syndrome and had more severe lesions and more frequently a focal pattern, including edge-ISR. Late angiographic findings (92% of eligible patients), including minimal lumen diameter (1.80±0.6 vs 2.01±0.6 mm,p=0.001) (absolute mean difference 0.21 mm; 95%CI 0.04-0.38;p=0.014) and restenosis rate (19 vs 9.5%, p |
---|---|
ISSN: | 0002-9149 1879-1913 |
DOI: | 10.1016/j.amjcard.2016.12.006 |